Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

US Patent 9725506 · Granted Aug 8, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic nuclease compositions and methods2025
Therapeutic nuclease compositions and methods2025
April and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
Therapeutic nuclease compositions and methods2022
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2022
Therapeutic nuclease compositions and methods2021
Levels of BCMA protein expression on B cells and use in methods of treating syst2020
Levels of BCMA protein expression on B cells and use in methods of treating syst2020
Levels of BCMA protein expression on B cells and use in methods of treating syst2020
CGAS in systemic lupus erythematosus (SLE)2019
Methods of producing a zcytor17 heterodimeric cytokine receptor2019